Company / Free Cash Flow
Tandem Diabetes Care Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$29.7M
FY2025
5-year range
-$58.6M / $22.4M
FY2021-FY2025
Trend
-694.1%
vs FY2024
Sector context
#128 of 151
Health Care
What the data says
Free Cash Flow changed -694% YoY in FY2025, a notable deviation from the 9-year average annual change of -262%.
Based on SEC 10-K filings.
-$30M in FY2025.
Improved from -$59M to -$30M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 151This company -$29.7M Sector average $779.8M
▼
-103.8% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 694.1% year-over-year.
- Ranks #128 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$29.7M | -694.1% |
| FY2024 | $5.0M | +108.5% |
| FY2023 | -$58.6M | -2040.0% |
| FY2022 | -$2.7M | -112.2% |
| FY2021 | $22.4M | +297.8% |
| FY2020 | -$11.3M | +84.3% |
| FY2019 | -$71.9M | -2.5% |
| FY2018 | -$70.1M | -8.6% |
| FY2017 | -$64.5M | +8.0% |
| FY2016 | -$70.1M | -8.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026